226 related articles for article (PubMed ID: 35264787)
1. Hepcidin in hepatocellular carcinoma.
Joachim JH; Mehta KJ
Br J Cancer; 2022 Jul; 127(2):185-192. PubMed ID: 35264787
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and DNA promoter methylation in hepatocellular carcinoma.
Udali S; Castagna A; Corbella M; Ruzzenente A; Moruzzi S; Mazzi F; Campagnaro T; De Santis D; Franceschi A; Pattini P; Gottardo R; Olivieri O; Perbellini L; Guglielmi A; Choi SW; Girelli D; Friso S
Eur J Clin Invest; 2018 Feb; 48(2):e12870. PubMed ID: 29235098
[TBL] [Abstract][Full Text] [Related]
3. Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.
Wahedi M; Wortham AM; Kleven MD; Zhao N; Jue S; Enns CA; Zhang AS
J Biol Chem; 2017 Nov; 292(44):18354-18371. PubMed ID: 28924039
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma.
Maegdefrau U; Arndt S; Kivorski G; Hellerbrand C; Bosserhoff AK
Lab Invest; 2011 Nov; 91(11):1615-23. PubMed ID: 21863061
[TBL] [Abstract][Full Text] [Related]
5. Splicing variant of hepcidin mRNA.
Sasaki K; Kohgo Y; Ohtake T
Vitam Horm; 2019; 110():131-141. PubMed ID: 30798808
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin and the BMP-SMAD pathway: An unexpected liaison.
Silvestri L; Nai A; Dulja A; Pagani A
Vitam Horm; 2019; 110():71-99. PubMed ID: 30798817
[TBL] [Abstract][Full Text] [Related]
7. The Action of JAK/STAT3 and BMP/HJV/SMAD Signaling Pathways on Hepcidin Suppression by Tucum-do-Cerrado in a Normal and Iron-Enriched Diets.
Arruda SF; Ramos LV; Barbosa JLA; Hankins NAC; Rodrigues PAM; Cunha MSBD
Nutrients; 2020 May; 12(5):. PubMed ID: 32456060
[TBL] [Abstract][Full Text] [Related]
8. Iron, hepcidin, and microcytosis in canine hepatocellular carcinoma.
Polak KZ; Schaffer P; Donaghy D; Zenk MC; Olver CS
Vet Clin Pathol; 2022 Jun; 51(2):208-215. PubMed ID: 35274348
[TBL] [Abstract][Full Text] [Related]
9. Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation.
Ohta K; Ito M; Chida T; Nakashima K; Sakai S; Kanegae Y; Kawasaki H; Aoshima T; Takabayashi S; Takahashi H; Kawata K; Shoji I; Sawasaki T; Suda T; Suzuki T
PLoS Pathog; 2023 Aug; 19(8):e1011591. PubMed ID: 37585449
[TBL] [Abstract][Full Text] [Related]
10. Abnormal iron uptake and liver cancer.
Chen J; Chloupková M
Cancer Biol Ther; 2009 Sep; 8(18):1699-708. PubMed ID: 19571663
[TBL] [Abstract][Full Text] [Related]
11. A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines.
Toki Y; Sasaki K; Tanaka H; Yamamoto M; Hatayama M; Ito S; Ikuta K; Shindo M; Hasebe T; Nakajima S; Sawada K; Fujiya M; Torimoto Y; Ohtake T; Kohgo Y
Biochem Biophys Res Commun; 2016 Aug; 476(4):501-507. PubMed ID: 27264950
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor β1 (TGF-β1) Activates Hepcidin mRNA Expression in Hepatocytes.
Chen S; Feng T; Vujić Spasić M; Altamura S; Breitkopf-Heinlein K; Altenöder J; Weiss TS; Dooley S; Muckenthaler MU
J Biol Chem; 2016 Jun; 291(25):13160-74. PubMed ID: 27129231
[TBL] [Abstract][Full Text] [Related]
13. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.
Ramos E; Kautz L; Rodriguez R; Hansen M; Gabayan V; Ginzburg Y; Roth MP; Nemeth E; Ganz T
Hepatology; 2011 Apr; 53(4):1333-41. PubMed ID: 21480335
[TBL] [Abstract][Full Text] [Related]
14. Disordered hepcidin-ferroportin signaling promotes breast cancer growth.
Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S
Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load.
Fillebeen C; Charlebois E; Wagner J; Katsarou A; Mui J; Vali H; Garcia-Santos D; Ponka P; Presley J; Pantopoulos K
Blood; 2019 Jan; 133(4):344-355. PubMed ID: 30538134
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma.
Kijima H; Sawada T; Tomosugi N; Kubota K
BMC Cancer; 2008 Jun; 8():167. PubMed ID: 18541040
[TBL] [Abstract][Full Text] [Related]
17. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.
Fujiwara T; Ikeda T; Nagasaka Y; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Tomosugi N; Harigae H
PLoS One; 2013; 8(9):e75568. PubMed ID: 24086573
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of iron regulatory hormone hepcidin by interferon α.
Ichiki K; Ikuta K; Addo L; Tanaka H; Sasaki Y; Shimonaka Y; Sasaki K; Ito S; Shindo M; Ohtake T; Fujiya M; Torimoto Y; Kohgo Y
J Gastroenterol Hepatol; 2014 Feb; 29(2):387-94. PubMed ID: 23926964
[TBL] [Abstract][Full Text] [Related]
19. Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice.
Poli M; Anower-E-Khuda F; Asperti M; Ruzzenenti P; Gryzik M; Denardo A; Gordts PLSM; Arosio P; Esko JD
J Biol Chem; 2019 Sep; 294(36):13292-13303. PubMed ID: 31315930
[TBL] [Abstract][Full Text] [Related]
20. The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo.
Zhang AS; Gao J; Koeberl DD; Enns CA
J Biol Chem; 2010 May; 285(22):16416-23. PubMed ID: 20363739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
